Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review
Author(s) -
Xiurong Cai,
Xing Li,
Jin-Xiang Lin,
Tiantian Wang,
Min Dong,
ZhanHong Chen,
Changchang Jia,
YingFen Hong,
Qu Lin,
XiangYuan Wu
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.15454
Subject(s) - hepatocellular carcinoma , medicine , adjuvant , meta analysis , transplantation , carcinoma , cytokine , immunology , adjuvant therapy , liver transplantation , oncology , cancer research , cancer
High recurrence rate after curative treatment is the major problem for hepatocellular carcinoma (HCC). Cytokine-induced killer cells (CIKs) therapy was extensively studied among HCC patients. However, the value of CIKs therapy was controversial. A meta-analysis was performed to investigate the efficacy of adjuvant CIKs after invasive treatments among HCC patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom